NewsPeople

Ram Mudaliar to lead AstraZeneca India’s CDI Division

Mudaliar holds a master’s degree in Biotechnology from Mumbai University in India

AstraZeneca India announced the appointment of Ram Mudaliar as the India lead of their Clinical Data & Insights (CDI) division. Mudaliar worked with AstraZeneca Canada, managing the delivery of the lung portfolio and leading oncology data management teams in the North American region and Europe. He has also worked as Interim Global Head of Oncology in Data Management for a brief period.

THIS CAN BE YOUR ADVERTISEMENT

Mudaliar’s appointment follows the launch of the CDI India division in October 2021.

As CDI India Lead, Mudaliar will be responsible for establishing and expanding the CDI footprint in India, liaising with CDI global and local leaders to develop and implement strategic decisions for the India site. He is also responsible for ensuring the local planning and coordination relating to facilities and enabling support for the India team, connecting with Facilities Management, Human Resources, IT, Compliance, R&D Site Leadership and other functions as required.

Mudaliar holds a master’s degree in Biotechnology from Mumbai University in India. Ram’s passion has always been about data and insights and is particularly fascinated by the possibilities it brings in enabling patient-centric solutions. Before joining AstraZeneca, Mudaliar has worked with Cognizant Technology Solutions where he was responsible for Clinical Data Management, Statistical Programming, Analysis and Medical Writing. Ram has been with AstraZeneca for over five years and has served various roles across countries and continents under the clinical data management domain.

Mudaliar said, “How we manage data is evolving, and the CDI division in India will prepare AstraZeneca for managing clinical data at exponential volume, scale and complexity. The team will support translating the huge volume of clinical information into meaningful insights for the organisation, further strengthening our ability to solve complex business problems and serve patients with an innovative data-driven approach. I am excited to be a part of this journey with AstraZeneca, establishing an effective workforce & innovation centre to handle all data-related aspects of clinical trials with a lean mindset.”

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close